NDC 68462-295

Trandolapril and Verapamil Hydrochloride

Trandolapril And Verapamil Hydrochloride

Trandolapril and Verapamil Hydrochloride is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., Usa. The primary component is Trandolapril; Verapamil Hydrochloride.

Product ID68462-295_2c098ea7-8f27-47c0-8ce3-855a172d8bf7
NDC68462-295
Product TypeHuman Prescription Drug
Proprietary NameTrandolapril and Verapamil Hydrochloride
Generic NameTrandolapril And Verapamil Hydrochloride
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2015-02-25
Marketing CategoryANDA / ANDA
Application NumberANDA079135
Labeler NameGlenmark Pharmaceuticals Inc., USA
Substance NameTRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
Active Ingredient Strength2 mg/1; mg/1
Pharm ClassesP-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68462-295-01

100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-01)
Marketing Start Date2015-02-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68462-295-10 [68462029510]

Trandolapril and Verapamil Hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA079135
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-25

NDC 68462-295-01 [68462029501]

Trandolapril and Verapamil Hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA079135
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-02-25

NDC 68462-295-90 [68462029590]

Trandolapril and Verapamil Hydrochloride TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA079135
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-02-25

Drug Details

Active Ingredients

IngredientStrength
TRANDOLAPRIL2 mg/1

OpenFDA Data

SPL SET ID:39bad727-af4c-4d20-933b-7f287e88099a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897844
  • 897781
  • 897853
  • 897783
    • UPC Code
  • 0368462822722
  • 0368462329016
  • 0368462296011
  • 0368462294017

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]

    NDC Crossover Matching brand name "Trandolapril and Verapamil Hydrochloride" or generic name "Trandolapril And Verapamil Hydrochloride"

    NDCBrand NameGeneric Name
    59762-0122Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    59762-0132Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    59762-0142Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-294Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-295Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-296Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-329Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    0074-3287TarkaTrandolapril and Verapamil Hydrochloride
    0074-3289TarkaTrandolapril and Verapamil Hydrochloride
    0074-3290TarkaTrandolapril and Verapamil Hydrochloride
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.